Compare EME & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EME | TEVA |
|---|---|---|
| Founded | 1987 | 1901 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Engineering & Construction | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.9B | 30.2B |
| IPO Year | N/A | N/A |
| Metric | EME | TEVA |
|---|---|---|
| Price | $635.62 | $30.84 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 9 |
| Target Price | ★ $693.60 | $32.11 |
| AVG Volume (30 Days) | 363.0K | ★ 8.8M |
| Earning Date | 10-30-2025 | 01-28-2026 |
| Dividend Yield | ★ 0.16% | N/A |
| EPS Growth | ★ 26.22 | N/A |
| EPS | ★ 24.83 | 0.62 |
| Revenue | $16,243,320,000.00 | ★ $16,776,000,000.00 |
| Revenue This Year | $16.15 | $4.62 |
| Revenue Next Year | $6.30 | $0.34 |
| P/E Ratio | ★ $24.64 | $50.57 |
| Revenue Growth | ★ 14.11 | 0.02 |
| 52 Week Low | $320.89 | $12.47 |
| 52 Week High | $778.64 | $31.99 |
| Indicator | EME | TEVA |
|---|---|---|
| Relative Strength Index (RSI) | 54.91 | 68.81 |
| Support Level | $610.00 | $31.17 |
| Resistance Level | $629.82 | $31.99 |
| Average True Range (ATR) | 15.17 | 0.55 |
| MACD | 1.98 | -0.20 |
| Stochastic Oscillator | 89.17 | 53.02 |
EMCOR Group Inc is a specialty contractor in the United States and a provider of electrical and mechanical construction and facilities services, building services, and industrial services. Its services are provided to a broad range of commercial, technology, manufacturing, industrial, healthcare, utility, and institutional customers through approximately 100 operating subsidiaries. The company's operating subsidiaries are organized into reportable segments: United States mechanical construction and facilities services, which derives key revenue; United States electrical construction and facilities services; United States building services; United States industrial services; and United Kingdom building services. Geographically, its key revenue is derived from the United States.
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.